Skip to Main Content

Paper Details

Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery.
J Pediatr Surg
3
2022
Author NameAffiliation
Samuel E Rice-TownsendSeattle Children's Hospital, United States University of Washington
Ron W ReederUniversity of Utah, Primary Children's Hospital
  • 1 - 2

Datasets

Release 1.2